Mobile

A randomized, international, open-label, phase II study of peripheral blood progenitor cell (PBPC) mobilization and engraftment with pegfilgrastim or filgrastim for autologous transplantation in subje...

Update Il y a 4 ans
Reference: EUCTR2006-000891-34

A randomized, international, open-label, phase II study of peripheral blood progenitor cell (PBPC) mobilization and engraftment with pegfilgrastim or filgrastim for autologous transplantation in subjects with multiple myeloma

Woman and Man

  • | Country :
    • -
  • | organs :
    • -
  • | Specialty :
    • -

Extract

To evaluate engraftment of PBPC’s mobilized by two different fixed doses of pegfilgrastim and a by-weight dose of filgrastim

Inclusion criteria

  • Multiple myeloma

Links